Systemic Family Therapy Combined with Sertraline Treatment for Depression
Shi Yunc
Abstract
Shi Yunc
Abstract
Objective To investigate the clinical efficacy of systemic family therapy combined with sertraline in the treatment of major depression.Methods Seventy-six patients were randomly assigned to treatment with sertraline alone(sertraline group,n=38) or in combination with systemic family therapy(therapy group,n=38).Hamilton Depression Rating Scale(HAMD-17),Gross Rating Scale(GAS) and Treatment Emergent Symptom Scale(TESS) were used to evaluate the effectiveness,adverse reactions and recurrence rate within 2 years.Results HAMD total scores,reduction rate and GAS scores significantly decreased at 2 and 4 weeks after treatment in both groups(P0.01),but no obvious differences were found between the two groups(P0.05).At 8 and 12 weeks after treatment,GAS scores and reduction rate of HAMD total scorers in combination group were significantly different from sertraline group(P0.05),and the recurrence rate within 2 years in combination group(20%,7/35) was significantly lower than that in sertraline group(36%,13/36)(P0.05).Conclusions The combination of systemic family therapy and sertraline is superior to sertraline alone for achieving long-term effectiveness and decreasing recurrence rate in the treatment of major depression.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical efficacy of systemic family therapy combined with sertraline in the treatment of major depression.Methods Seventy-six patients were randomly assigned to treatment with sertraline alone(sertraline group,n=38) or in combination with systemic family therapy(therapy group,n=38).Hamilton Depression Rating Scale(HAMD-17),Gross Rating Scale(GAS) and Treatment Emergent Symptom Scale(TESS) were used to evaluate the effectiveness,adverse reactions and recurrence rate within 2 years.Results HAMD total scores,reduction rate and GAS scores significantly decreased at 2 and 4 weeks after treatment in both groups(P0.01),but no obvious differences were found between the two groups(P0.05).At 8 and 12 weeks after treatment,GAS scores and reduction rate of HAMD total scorers in combination group were significantly different from sertraline group(P0.05),and the recurrence rate within 2 years in combination group(20%,7/35) was significantly lower than that in sertraline group(36%,13/36)(P0.05).Conclusions The combination of systemic family therapy and sertraline is superior to sertraline alone for achieving long-term effectiveness and decreasing recurrence rate in the treatment of major depression.
Key concepts: Sertraline, Hamd, Medicine, Depression (economics), Rating scale, Hamilton depression scale, Internal medicine, Hamilton Rating Scale for Depression